Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

monoclonal antibody B013

A monoclonal antibody targeting an as of yet undisclosed tumor-associated antigen (TAA), with potential antineoplastic activity. Upon administration of B013, the monoclonal antibody targets and binds to the TAA expressed on tumor cells. This may result in the death of tumor cells expressing the TAA through an as of yet not elucidated mechanism of action.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	B 013 B-013 B013

monoclonal antibody B013

Search NCI's Drug Dictionary